The ultimate success of living-radical polymerizations will depend on whether they can be used to make materials with unique properties in an economical and acceptable manufacturing process. We report a major step in this direction for the SFRP process by demonstrating that a miniemulsion process can be used to polymerize monomers to high conversion with a high degree of livingness and that this process can be used to synthesize block copolymers. The key to the polymerizations is the use of a nitroxide-terminated oligomer to initiate the miniemulsions. Miniemulsions are performed at 135 °C to greater than 99% conversion to give polystyrenes with polydispersities between 1.15 and 1.25. Chain extension studies show these materials to have a high degree of livingness. Reaction of these polystyrene latexes with n-butyl acrylate lead to the first block copolymers completely made under SFRP miniemulsion conditions.
The phototransposition reactions in acetonitrile of p-, m-, and o-methylbenzonitrile have been studied. Any one of the three is converted to the other two by either a 1,2-or 1,3-isomerization in a primary photochemical step. However, the reactivities are quite different with the relative values for para:meta:ortho ) 32:4:1. For both the para and meta isomers, extended irradiations approach a calculated steady-state composition of para:meta:ortho ) 3:20:77. Quenching of the excited triplet state of the para and meta isomers with 2,4-dimethyl-1,3-butadiene indicates that these reactions are occurring from the excited singlet state. Irradiation of selectively labeled 2,6-dideuterio-4-methylbenzonitrile demonstrates that only the cyano-substituted carbon undergoes migration.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.